MDXG
NASDAQ · Biotechnology
Mimedx Group Inc
$3.72
+0.05 (+1.36%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+549.2% upside
Low Target
$19.42
Average Target
$24.15
High Target
$35.38
Current Price
$3.72
Current
$3.72
$3.72
Target
$24.15
$24.15
$19.42
$24.15 avg
$35.38
Scenario Analysis
Bear Case
$19.42
422.0%
Low target
Base Case
$24.15
+549.2%
Avg target
Bull Case
$35.38
+851.1%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$7.99
-53.4% from high
52-Week Low
$3.03
+22.8% from low
Target vs 52W High
$24.15
+202.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.0% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +190.0% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -6.4% |
| REGN | Buy | 38 | 71% | $76.80 | -87.6% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -64.5% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.7% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -39.1% |